clinical application of her2-directed therapies in breast cancer
DESCRIPTION
Clinical Application of HER2-Directed Therapies in Breast Cancer. HERA Results: Adjuvant Trastuzumab (8-Year Follow-up): OS – 2 y vs 1 y. ALTTO Trial: Schema. MARIANNE: Phase 3 Trial in HER2+ Breast Cancer (Locally Recurrent/Progressive Advanced or Metastatic). Abbreviations. - PowerPoint PPT PresentationTRANSCRIPT